Latest News and Press Releases

NEW YORK, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Mid Atlantic Bio Angels (MABA) announces today that Plico Biotech (http://plicobiote.ch), which is developing biotherapeutic drugs for the treatment of...

PHILADELPHIA, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that Avisi Technologies, LLC, which develops an eye implant for glaucoma, was named “Best in Show” by...

NEW YORK, June 21, 2018 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that Bonbouton, a New York-based company developing insole sensor technology to more rapidly identify...

NEW YORK, May 04, 2018 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that EndObetes, which is developing an endoscopic treatment for obesity and associated type-2 diabetes, was...

NEW YORK, March 22, 2018 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that Prolifagen LLC, which develops novel molecules for prevention of heart failure, was named “Best in...

NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- Mid Atlantic Bio Angels (MABA) announces today the initiation of a second closed-end investment pool (Pool II) funded by current, active MABA members,...

NEW YORK, March 07, 2018 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that Renovacor, a biotechnology company developing a gene therapy for heart failure, was named “Best in...

NEW YORK, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that Group K Diagnostics (Group K), a Philadelphia-based diagnostics company developing a multi-test...

NEW YORK, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Mid Atlantic Bio Angels (MABA) announces today that it has made its ninth investment in a company called Elysium Therapeutics, Inc., which is developing a...

NEW YORK, Nov. 10, 2017 (GLOBE NEWSWIRE) -- Mid Atlantic Bio Angels (MABA) announces today that it has made an investment in Boston-based New View Surgical., which has developed a proprietary...